206 related articles for article (PubMed ID: 22202440)
1. Microbiology of regressive autism.
Finegold SM; Downes J; Summanen PH
Anaerobe; 2012 Apr; 18(2):260-2. PubMed ID: 22202440
[TBL] [Abstract][Full Text] [Related]
2. Desulfovibrio species are potentially important in regressive autism.
Finegold SM
Med Hypotheses; 2011 Aug; 77(2):270-4. PubMed ID: 21592674
[TBL] [Abstract][Full Text] [Related]
3. State of the art; microbiology in health and disease. Intestinal bacterial flora in autism.
Finegold SM
Anaerobe; 2011 Dec; 17(6):367-8. PubMed ID: 21524713
[TBL] [Abstract][Full Text] [Related]
4. First isolation of Desulfovibrio from the human vaginal flora.
Ichiishi S; Tanaka K; Nakao K; Izumi K; Mikamo H; Watanabe K
Anaerobe; 2010 Jun; 16(3):229-33. PubMed ID: 20159048
[TBL] [Abstract][Full Text] [Related]
5. [Rate of isolation of "C. difficile" from stools of hospitalized patients: susceptibility of 75 strains (author's transl)].
Tytgat F
Ann Microbiol (Paris); 1980; 131B(1):11-20. PubMed ID: 7458111
[TBL] [Abstract][Full Text] [Related]
6. Fecal lactoferrin and Clostridium spp. in stools of autistic children.
Martirosian G; Ekiel A; Aptekorz M; Wiechuła B; Kazek B; Jankowska-Steifer E; Jóźwiak J; Moskalewski S
Anaerobe; 2011 Feb; 17(1):43-5. PubMed ID: 21167951
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal microflora studies in late-onset autism.
Finegold SM; Molitoris D; Song Y; Liu C; Vaisanen ML; Bolte E; McTeague M; Sandler R; Wexler H; Marlowe EM; Collins MD; Lawson PA; Summanen P; Baysallar M; Tomzynski TJ; Read E; Johnson E; Rolfe R; Nasir P; Shah H; Haake DA; Manning P; Kaul A
Clin Infect Dis; 2002 Sep; 35(Suppl 1):S6-S16. PubMed ID: 12173102
[TBL] [Abstract][Full Text] [Related]
8. Therapy and epidemiology of autism--clostridial spores as key elements.
Finegold SM
Med Hypotheses; 2008; 70(3):508-11. PubMed ID: 17904761
[TBL] [Abstract][Full Text] [Related]
9. Pyrosequencing study of fecal microflora of autistic and control children.
Finegold SM; Dowd SE; Gontcharova V; Liu C; Henley KE; Wolcott RD; Youn E; Summanen PH; Granpeesheh D; Dixon D; Liu M; Molitoris DR; Green JA
Anaerobe; 2010 Aug; 16(4):444-53. PubMed ID: 20603222
[TBL] [Abstract][Full Text] [Related]
10. Isolation and evaluation of susceptibility to sulphasalazine of Desulfovibrio desulfuricans strains from the human digestive tract.
Dzierzewicz Z; Cwalina B; Gawlik B; Wilczok T; Gonciarz Z
Acta Microbiol Pol; 1997; 46(2):175-87. PubMed ID: 9429289
[TBL] [Abstract][Full Text] [Related]
11. Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection.
Citron DM; Babakhani F; Goldstein EJ; Nagaro K; Sambol S; Sears P; Shue YK; Gerding DN
Anaerobe; 2009 Dec; 15(6):234-6. PubMed ID: 19755166
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterisation of the gut microflora of healthy and inflammatory bowel disease cats using fluorescence in situ hybridisation with special reference to Desulfovibrio spp.
Inness VL; McCartney AL; Khoo C; Gross KL; Gibson GR
J Anim Physiol Anim Nutr (Berl); 2007 Feb; 91(1-2):48-53. PubMed ID: 17217390
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility of Clostridium difficile strains isolated from hospitalised patients with acute diarrhoea.
Niyogi SK
J Diarrhoeal Dis Res; 1992 Sep; 10(3):156-8. PubMed ID: 1430970
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility of anaerobic bacteria from the intestinal microflora of healthy children and antimicrobial-treated children in Nicaragua.
Cáceres M; Carera E; Palmgren AC; Nord CE
Rev Esp Quimioter; 1998 Sep; 11(3):221-8. PubMed ID: 9795308
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility to antibiotics and biochemical properties of Desulfovibrio desulfuricans strains.
Dzierzewicz Z; Cwalina B; Jaworska-Kik M; Weglarz L; Wilczok T
Acta Pol Pharm; 2001; 58(6):439-45. PubMed ID: 12197616
[TBL] [Abstract][Full Text] [Related]
16. Desulfovibrio legallii prosthetic shoulder joint infection and review of antimicrobial susceptibility and clinical characteristics of Desulfovibrio infections.
Vasoo S; Mason EL; Gustafson DR; Cunningham SA; Cole NC; Vetter EA; Steinmann SP; Wilson WR; Patel R; Berbari EF; Henry NK
J Clin Microbiol; 2014 Aug; 52(8):3105-10. PubMed ID: 24850351
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of Clostridium difficile isolates to 12 antimicrobial agents.
Gianfrilli P; Luzzi I; Pantosti A; Occhionero M
Chemioterapia; 1984 Feb; 3(1):41-4. PubMed ID: 6535652
[TBL] [Abstract][Full Text] [Related]
18. [Anaerobic intestinal microflora in pathogenesis of autism?].
Martirosian G
Postepy Hig Med Dosw (Online); 2004; 58():349-51. PubMed ID: 15459553
[TBL] [Abstract][Full Text] [Related]
19. Lack of value of repeat stool testing for Clostridium difficile toxin.
Mohan SS; McDermott BP; Parchuri S; Cunha BA
Am J Med; 2006 Apr; 119(4):356.e7-8. PubMed ID: 16564786
[TBL] [Abstract][Full Text] [Related]
20. [Bacteroides fragilis group in non-diarrheal human feces and its antimicrobial susceptibility].
Rodríguez E; Gamboa MM; Rodríguez C; Vargas P
Rev Esp Quimioter; 2006 Dec; 19(4):357-62. PubMed ID: 17235405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
